Research
Energy balance
The article provides an outlook on new weight reduction medications that are about to be approved or are currently in Phase 3 of approval studies.
Be aware of new medications that may soon be available for weight reduction.
StrongSupportsmedium confidence
gibt einen Ausblick auf neue Arzneimittel zur Gewichtsreduktion, deren Zulassung kurz bevor steht oder die sich derzeit in Phase 3 der Zulassungsstudien befinden.
Why this rating
The claim is based on the author's summary of the current research landscape.
Source
Ausblick auf neue Arzneimittel zur Gewichtsreduktion
Stefan Engeli · Adipositas - Ursachen Folgeerkrankungen Therapie · 2022
DOI 10.1055/a-1722-5945
reviewCited 1×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- The use of weight reduction medications as an adjunct therapy alongside dietary, exercise, and behavioral interventions is clearly described in current and future guidelines of the German Obesity Society.Strong
- There have been some adjustments in weight reduction medications available on the German market in the last two years.Strong
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →